Aptamers are short, single-stranded nucleic acids that can fold into specific three-dimensional structures, allowing them to ...

Ultrasound-mediated nanobubbles improve cancer therapy by softening tumors, enhancing lipid nanoparticle distribution, and ...

Janux Therapeutics has dosed the first participant in a Phase I clinical trial of JANX011, a Cluster of Differentiation 19 ...

MILAN — Immune-based treatments continue to fall short in myelodysplastic syndromes (MDS). Now, experts from the European Hematology Association’s (EHA) Specialized Working Group on MDS here at the ...

Aquaculture plays a critical role in global food security, yet its sustainability is increasingly challenged by reliance on conventional feed ingredients, ...

Attivare will use MSR biomaterial scaffolds like this to first develop treatments for patients with solid tumors and heme malignancies who do not respond to immunotherapies yet. The immune-modulating ...

Adenosine deaminase 2 (ADA2) has been identified as a regulator of toll-like receptor 9 (TLR9) activation in response to nucleic acids, according to a recent study. ADA2, previously known for its role ...

Researchers with the Knight Initiative for Brain Resilience have modified a well-known immune protein to spark the growth of new neurons, ease brain inflammation, and improve cognition in old mice.

Secondary infections caused by bacteria or viruses during hospital care remain a long-standing global challenge, despite ...

Research in psychoneuroimmunology suggests strong relationships may reduce stress and inflammation, indirectly supporting immunity.